SS
CRDF icon

SBI Securities’s Cardiff Oncology CRDF Stock Holding History

SBI Securities’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$233 Hold
144
– – ﹤0.01% 3166
2025
Q4 		$405 Sell
144
-1
-0.7% -$2 ﹤0.01% 2949
2025
Q3 		$299 Sell
145
-819
-85% -$2.26K ﹤0.01% 3190
2025
Q2 		$3.04K Buy
964
+230
+31% +$702 ﹤0.01% 2217
2025
Q1 		$2.31K Buy
734
+79
+12% +$312 ﹤0.01% 2229
2024
Q4 		$2.84K Buy
+655
New +$2.05K ﹤0.01% 2150

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return

SBI Securities's CRDF Position: Q1 2026 in Review

SBI Securities held its Cardiff Oncology (CRDF) position steady in Q1 2026 at 144 shares worth $233. The position accounts for ﹤0.01% of the portfolio, ranked #3166.

SBI Securities first reported a position in CRDF in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.04K in Q2 2025. 116 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.

  • SBI Securities held 144 shares of Cardiff Oncology worth $233 as of Q1 2026.
  • SBI Securities left its Cardiff Oncology share count unchanged in Q1 2026.
  • Cardiff Oncology made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #3166 holding.
  • SBI Securities first reported a position in Cardiff Oncology in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's Cardiff Oncology position peaked at $3.04K in Q2 2025.
  • 116 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.